Cargando…
Humanized anti-DEspR IgG4(S228P) antibody increases overall survival in a pancreatic cancer stem cell-xenograft peritoneal carcinomatosis rat(nu/nu) model
BACKGROUND: Pancreatic peritoneal carcinomatosis (PPC), with the worst median overall-survival (mOS), epitomizes the incurability of metastatic cancer. Cancer stem cells (CSCs) underpin this incurability. However, inhibitors of CSC-stemness fail to increase mOS in cancer patients despite preclinical...
Autores principales: | Gromisch, Christopher M., Tan, Glaiza L. A., Pasion, Khristine Amber, Moran, Ann-Marie, Gromisch, Matthew S., Grinstaff, Mark W., Carr, Francis J., Herrera, Victoria L. M., Ruiz-Opazo, Nelson |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048286/ https://www.ncbi.nlm.nih.gov/pubmed/33853558 http://dx.doi.org/10.1186/s12885-021-08107-w |
Ejemplares similares
-
Anti-DEspR antibody treatment improves survival and reduces neurologic deficits in a hypertensive, spontaneous intracerebral hemorrhage (hsICH) rat model
por: Herrera, Victoria L. M., et al.
Publicado: (2023) -
Confirmation of translatability and functionality certifies the dual endothelin1/VEGFsp receptor (DEspR) protein
por: Herrera, Victoria L. M., et al.
Publicado: (2016) -
DEspR Roles in Tumor Vasculo-Angiogenesis, Invasiveness, CSC-Survival and Anoikis Resistance: A ‘Common Receptor Coordinator’ Paradigm
por: Herrera, Victoria L., et al.
Publicado: (2014) -
“Rogue” neutrophil-subset [DEspR+CD11b+/CD66b+] immunotype is an actionable therapeutic target for neutrophilic inflammation-mediated tissue injury – studies in human, macaque and rat LPS-inflammation models
por: Carstensen, Saskia, et al.
Publicado: (2022) -
DEspR(high) neutrophils are associated with critical illness in COVID-19
por: deKay, Joanne T., et al.
Publicado: (2021)